Proteomic Analysis of Exudates from Chronic Ulcer of Diabetic Foot Treated with Scorpion Antimicrobial Peptide

Figure 1

Changes of ulcer wounds in diabetic foot patients during different treatment periods. (a) is the ulcer wound changes in the lesion site of patients with No. 1 diabetic foot after antimicrobial peptide treatment in the early, middle, and late stage; (b) is the ulcer wound changes in the lesion site of patients with No. 2 diabetic foot after antimicrobial peptide treatment in the early, middle, and late stage; (c) is the ulcer wound changes in the lesion site of patients with No. 3 diabetic foot after antimicrobial peptide treatment in the early, middle, and late stages. The initial ulcer areas of the three patients were about 40 cm², 10 cm², and 6 cm², respectively, and the amount of wound exudate was between 100 μL and 2 mL.